Table of contents:
Coronavirus that causes COVID-19 is still mutating to produce new variants. COVID-19 Lambda variant is one of the mutation variants of the Corona virus which is starting to be found in many countries, but has not been confirmed to enter Indonesia
Lambda variant COVID-19 or C.37 was first identified in Peru in December 2020. Lambda variant COVID-19 has 2 mutations in the SARS-CoV-2 spike protein receptor binding domain, namely mutations L452Q and F490S.
Coronavirus Lambda variant was first found in many South American countries. However, this virus is known to have spread to various other countries, such as the UK, the United States, and Canada.
The symptoms of the Lambda variant of COVID-19 are not much different from the symptoms of COVID-19 in general, namely fever, cough, runny nose, muscle aches, headache, weakness and impaired sense of smell (anosmia).
COVID-19 Lambda Variant
COVID-19 previously discovered variants, namely Alpha, Beta, Delta, and Gamma variants, have now been categorized by the World He alth Organization (WHO) as variants of concern.
This classification indicates that these variants have been shown to be more infectious and are at risk of causing more severe or difficult-to-treat COVID-19 symptoms.
Different from the Lambda variant of COVID-19, until now this variant is still classified as a variant of interest (variant of interest).
This is because the Lambda variant of COVID-19 is predicted to have the potential to spread more quickly, cause more severe COVID-19 symptoms, or reduce the effectiveness of the COVID-19 vaccine.
However, until now, there has not been sufficient evidence of these things. Therefore, research and monitoring are still being carried out to determine whether the Lambda variant of COVID-19 is more dangerous than other variants or not.
Nevertheless, it is possible that the COVID-19 Lambda variant will be classified as a variant of concern. This can happen, if in the future the Lambda variant of COVID-19 is proven to be more easily and quickly transmitted or causes more severe COVID-19 symptoms.
Covid-19 Vaccine Ability to Fight COVID-19 Lambda Variant
WHO stated that the existing COVID-19 vaccine is still capable and effective in forming the body's immune response to the SARS-CoV-2 virus and its variants, including the Lambda variant.
This is evidenced by a study discussing the effectiveness of COVID-19 vaccines, such as the Astrazeneca vaccine and the mRNA vaccine, against the Lambda variant of COVID-19. This research states that the COVID-19 vaccine in full doses can still provide protection against the Lambda variant of COVID-19 and other variant types of the Corona virus.
So, it can be concluded that COVID-19 vaccination remains an effective way to slow down the spread of the disease and reduce the risk of suffering from severe symptoms due to COVID-19 infection, including Lambda variant.
Therefore, don't hesitate to get vaccinated against COVID-19 if you have received the quota and vaccination schedule, OK.
In addition, it is important to continue to apply the applicable he alth protocols, such as wearing masks, frequently washing hands with running water and soap or hand sanitizer, maintaining physical distance from other people, and avoiding crowds, in order to prevent transmission of the COVID-19 disease. 19.
If you still have questions regarding COVID-19 Lambda variant or vaskin COVID-19, you can also ask the doctor via chat on the ALODOKTER application.